These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 12410794)
21. Human Enterovirus 71 Protein Displayed on the Surface of Saccharomyces cerevisiae as an Oral Vaccine. Zhang C; Wang Y; Ma S; Li L; Chen L; Yan H; Peng T Viral Immunol; 2016 Jun; 29(5):288-95. PubMed ID: 27259043 [TBL] [Abstract][Full Text] [Related]
22. Protective efficacy of a plasmid DNA encoding Japanese encephalitis virus envelope protein fused to tissue plasminogen activator signal sequences: studies in a murine intracerebral virus challenge model. Ashok MS; Rangarajan PN Vaccine; 2002 Feb; 20(11-12):1563-70. PubMed ID: 11858863 [TBL] [Abstract][Full Text] [Related]
23. Spontaneous C-cleavage of a truncated intein as fusion tag to produce tag-free VP1 inclusion body nanoparticle vaccine against CVB3-induced viral myocarditis by the oral route. Qi X; Lu Q; Hu J; Xiong S Microb Cell Fact; 2019 Apr; 18(1):66. PubMed ID: 30947747 [TBL] [Abstract][Full Text] [Related]
24. Expression of VP1 protein in the milk of transgenic mice: a potential oral vaccine protects against enterovirus 71 infection. Chen HL; Huang JY; Chu TW; Tsai TC; Hung CM; Lin CC; Liu FC; Wang LC; Chen YJ; Lin MF; Chen CM Vaccine; 2008 Jun; 26(23):2882-9. PubMed ID: 18450335 [TBL] [Abstract][Full Text] [Related]
25. Development of a DNA vaccine against chicken anemia virus by using a bicistronic vector expressing VP1 and VP2 proteins of CAV. Moeini H; Omar AR; Rahim RA; Yusoff K Comp Immunol Microbiol Infect Dis; 2011 May; 34(3):227-36. PubMed ID: 21146874 [TBL] [Abstract][Full Text] [Related]
26. Immune responses generated by Lactobacillus as a carrier in DNA immunization against foot-and-mouth disease virus. Li YG; Tian FL; Gao FS; Tang XS; Xia C Vaccine; 2007 Jan; 25(5):902-11. PubMed ID: 17028078 [TBL] [Abstract][Full Text] [Related]
27. Enhancement of VP1-specific immune responses and protection against EMCV-K challenge by co-delivery of IL-12 DNA with VP1 DNA vaccine. Suh YS; Ha SJ; Lee CH; Sin JI; Sung YC Vaccine; 2001 Feb; 19(15-16):1891-8. PubMed ID: 11228358 [TBL] [Abstract][Full Text] [Related]
28. Intranasal delivery of chitosan-DNA vaccine generates mucosal SIgA and anti-CVB3 protection. Xu W; Shen Y; Jiang Z; Wang Y; Chu Y; Xiong S Vaccine; 2004 Sep; 22(27-28):3603-12. PubMed ID: 15315839 [TBL] [Abstract][Full Text] [Related]
29. Immunogenicity of a truncated enterovirus 71 VP1 protein fused to a Newcastle disease virus nucleocapsid protein fragment in mice. Ch'ng WC; Saw WT; Yusoff K; Shafee N Acta Virol; 2011; 55(3):227-33. PubMed ID: 21978156 [TBL] [Abstract][Full Text] [Related]
30. Production of cross-reactive peptide antibodies against viral capsid proteins of human enterovirus B to apply diagnostic reagent. Jeong SY; Ahn J; Cho YJ; Kim YJ; Kim DS; Jee Y; Lee H; Nam JH Microbiol Immunol; 2007; 51(11):1091-8. PubMed ID: 18037786 [TBL] [Abstract][Full Text] [Related]
31. Expression of an antigenic adenovirus epitope in a group B coxsackievirus. Höfling K; Tracy S; Chapman N; Kim KS; Smith Leser J J Virol; 2000 May; 74(10):4570-8. PubMed ID: 10775593 [TBL] [Abstract][Full Text] [Related]
32. Expression and immunogenicity of novel subunit enterovirus 71 VP1 antigens. Xu J; Wang S; Gan W; Zhang W; Ju L; Huang Z; Lu S Biochem Biophys Res Commun; 2012 Apr; 420(4):755-61. PubMed ID: 22450314 [TBL] [Abstract][Full Text] [Related]
33. Antigenic characteristics of the complete and truncated capsid protein VP1 of enterovirus 71. Zhang J; Dong M; Jiang B; Dai X; Meng J Virus Res; 2012 Aug; 167(2):337-42. PubMed ID: 22659489 [TBL] [Abstract][Full Text] [Related]
34. A virus-like particle vaccine protects mice against coxsackievirus A10 lethal infection. Zhou Y; Zhang C; Liu Q; Gong S; Geng L; Huang Z Antiviral Res; 2018 Apr; 152():124-130. PubMed ID: 29470994 [TBL] [Abstract][Full Text] [Related]
35. Vaccination of mice with plasmids expressing processed capsid protein of foot-and-mouth disease virus--importance of dominant and subdominant epitopes for antigenicity and protection. Frimann TH; Barfoed AM; Aasted B; Kamstrup S Vaccine; 2007 Aug; 25(33):6191-200. PubMed ID: 17640782 [TBL] [Abstract][Full Text] [Related]
36. Immune responses of recombinant adenovirus co-expressing VP1 of foot-and-mouth disease virus and porcine interferon alpha in mice and guinea pigs. Du Y; Dai J; Li Y; Li C; Qi J; Duan S; Jiang P Vet Immunol Immunopathol; 2008 Aug; 124(3-4):274-83. PubMed ID: 18511133 [TBL] [Abstract][Full Text] [Related]
38. A Broadly Cross-protective Vaccine Presenting the Neighboring Epitopes within the VP1 GH Loop and VP2 EF Loop of Enterovirus 71. Xu L; He D; Yang L; Li Z; Ye X; Yu H; Zhao H; Li S; Yuan L; Qian H; Que Y; Kuo Shih JW; Zhu H; Li Y; Cheng T; Xia N Sci Rep; 2015 Aug; 5():12973. PubMed ID: 26243660 [TBL] [Abstract][Full Text] [Related]
39. Enhanced immune response with foot and mouth disease virus VP1 and interleukin-1 fusion genes. Park JH; Kim SJ; Oem JK; Lee KN; Kim YJ; Kye SJ; Park JY; Joo YS J Vet Sci; 2006 Sep; 7(3):257-62. PubMed ID: 16871020 [TBL] [Abstract][Full Text] [Related]
40. Vaccination with coxsackievirus B3 virus-like particles elicits humoral immune response and protects mice against myocarditis. Zhang L; Parham NJ; Zhang F; Aasa-Chapman M; Gould EA; Zhang H Vaccine; 2012 Mar; 30(13):2301-8. PubMed ID: 22306858 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]